SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

26 Jul 2024 Evaluate
The company witnessed a 7.10% growth in the revenue at Rs. 99.13 millions for the quarter ended June 2024 as compared to Rs. 92.56 millions during the year-ago period.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 12.90  millions as against Rs. 14.44 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 37.73 millions from 38.67 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 99.13 92.56 7.10 99.13 92.56 7.10 408.34 424.24 -3.75
Other Income 3.37 2.01 67.66 3.37 2.01 67.66 10.04 10.84 -7.38
PBIDT 37.73 38.67 -2.43 37.73 38.67 -2.43 182.26 217.87 -16.34
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.12 0.00
PBDT 37.73 38.67 -2.43 37.73 38.67 -2.43 182.26 216.75 -15.91
Depreciation 17.27 18.01 -4.11 17.27 18.01 -4.11 70.85 71.73 -1.23
PBT 20.46 20.66 -0.97 20.46 20.66 -0.97 111.41 145.02 -23.18
TAX 7.56 6.22 21.54 7.56 6.22 21.54 28.43 29.17 -2.54
Deferred Tax 7.56 6.22 21.54 7.56 6.22 21.54 28.43 29.17 -2.54
PAT 12.90 14.44 -10.66 12.90 14.44 -10.66 82.98 115.85 -28.37
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 38.06 41.78 -8.90 38.06 41.78 -8.90 44.63 51.36 -13.09

Zenotech Laboratorie Share Price

49.37 1.34 (2.79%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×